We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ALMS market cap is 437.43M. The company's latest EPS is USD -2.8488 and P/E is -2.82.
Quarter End | Mar 2024 | Jun 2024 |
---|---|---|
USD (US$) | ||
Total Revenue | 0 | 0 |
Operating Income | -47.59M | -56.14M |
Net Income | -49.85M | -56.51M |
Year End December 30 2023 | 2023 |
---|---|
USD (US$) | |
Total Revenue | 0 |
Operating Income | -158.17M |
Net Income | -154.99M |
Quarter End | Mar 2024 | Jun 2024 |
---|---|---|
USD (US$) | ||
Total Assets | 177.38M | 265.18M |
Total Liabilities | 563.3M | 64.7M |
Total Equity | -385.93M | -438.76M |
Year End December 30 2023 | 2023 |
---|---|
USD (US$) | |
Total Assets | 89.61M |
Total Liabilities | 428.87M |
Total Equity | -339.26M |
Market Cap | 437.43M |
Price to Earnings Ratio | -2.82 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 9.51 |
Price to Book Ratio | -1.29 |
Dividend Yield | - |
Shares Outstanding | 54.41M |
Average Volume (1 week) | 185.67k |
Average Volume (1 Month) | 149.77k |
52 Week Change | -40.44% |
52 Week High | 13.50 |
52 Week Low | 7.66 |
Spread (Intraday) | 0.53 (6.24%) |
Company Name | Alumis Inc |
Address |
3500 s dupont hwy dover, delaware 19901 |
Website | https://www.alumis.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions